Starting at around day 100, TCL1 Nfat2−/− mice exhibited a significant acceleration of leukaemia proliferation as compared to controls with intact NFAT2 expression as documented by significantly increased lymphocytes and CD19+CD5+ CLL cells (Fig. 2c, d). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.